Involvement of ceramide in the propagation of Japanese encephalitis virus

Journal of Virology

Volumn 84, Issue 6, 2010, Pages 2798-2807

  Tani, Hideki ^a   Shiokawa, Mai ^a   Kaname, Yuuki ^a   Kambara, Hiroto ^a   Mori, Yoshio ^a   Abe, Takayuki ^a   Moriishi, Kohji ^a   Matsuura, Yoshiharu ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CERAMIDE; CHOLESTEROL; CLATHRIN; METHYL BETA CYCLODEXTRIN; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; VIRUS ENVELOPE PROTEIN;

ACIDITY; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROLYSIS; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALS; CELL LINE; CERAMIDES; CHOLESTEROL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GENOME, VIRAL; HUMANS; SPHINGOMYELIN PHOSPHODIESTERASE; VIRUS INTERNALIZATION; VIRUS REPLICATION;

JAPANESE ENCEPHALITIS VIRUS; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 77649092153     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02499-09     Document Type: Article

References (50)

1. Aizaki, H., K. Morikawa, M. Fukasawa, H. Hara, Y. Inoue, H. Tani, K. Saito, M. Nishijima, K. Hanada, Y. Matsuura, M. M. Lai, T. Miyamura, T. Wakita, and T. Suzuki. 2008. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 82:5715-5724.
2. Bollinger, C. R., V. Teichgraber, and E. Gulbins. 2005. Ceramide-enriched membrane domains. Biochim. Biophys. Acta 1746:284-294.
3. Boonsanay, V., and D. R. Smith. 2007. Entry into and production of the Japanese encephalitis virus from C6/36 cells. Intervirology 50:85-92.
4. Chatterjee, S. 1993. Neutral sphingomyelinase increases the binding, internalization, and degradation of low density lipoproteins and synthesis of cholesteryl ester in cultured human fibroblasts. J. Biol. Chem. 268:3401-3406.
5. Chazal, N., and D. Gerlier. 2003. Virus entry, assembly, budding, and membrane rafts. Microbiol. Mol. Biol. Rev. 67:226-237, table of contents.
6. Finnegan, C. M., S. S. Rawat, E. H. Cho, D. L. Guiffre, S. Lockett, A. H. Merrill, Jr., and R. Blumenthal. 2007. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J. Virol. 81:5294-5304.
7. Finnegan, C. M., S. S. Rawat, A. Puri, J. M. Wang, F. W. Ruscetti, and R. Blumenthal. 2004. Ceramide, a target for antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 101:15452-15457.
8. Grassme, H., E. Gulbins, B. Brenner, K. Ferlinz, K. Sandhoff, K. Harzer, F. Lang, and T. F. Meyer. 1997. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91:605-615.
9. Grassme, H., V. Jendrossek, A. Riehle, G. von Kurthy, J. Berger, H. Schwarz, M. Weller, R. Kolesnick, and E. Gulbins. 2003. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 9:322-330.
10. Grassme, H., A. Riehle, B. Wilker, and E. Gulbins. 2005. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J. Biol. Chem. 280:26256-26262.
11. Gubler, D., G. Kuno, and L. Markoff. 2007. Flaviviruses, p. 1153-1252. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol. 1. Lippincott-Williams & Wilkins, Philadelphia, PA.
12. Hanada, K., K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, M. Fukasawa, and M. Nishijima. 2003. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426:803-809.
13. Herz, J., J. Pardo, H. Kashkar, M. Schramm, E. Kuzmenkina, E. Bos, K. Wiegmann, R. Wallich, P. J. Peters, S. Herzig, E. Schmelzer, M. Kronke, M. M. Simon, and O. Utermohlen. 2009. Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. Nat. Immunol. 10:761-768.
14. Ikeda, M., K. Abe, M. Yamada, H. Dansako, K. Naka, and N. Kato. 2006. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44:117-125.
15. Jan, J. T., S. Chatterjee, and D. E. Griffin. 2000. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 74:6425-6432.
16. Kapadia, S. B., H. Barth, T. Baumert, J. A. McKeating, and F. V. Chisari. 2007. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81:374-383.
17. Kapadia, S. B., and F. V. Chisari. 2005. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. U. S. A. 102:2561-2566.
18. Krishnan, M. N., B. Sukumaran, U. Pal, H. Agaisse, J. L. Murray, T. W. Hodge, and E. Fikrig. 2007. Rab 5 is required for the cellular entry of dengue and West Nile viruses. J. Virol. 81:4881-4885.
19. Lang, P. A., M. Schenck, J. P. Nicolay, J. U. Becker, D. S. Kempe, A. Lupescu, S. Koka, K. Eisele, B. A. Klarl, H. Rubben, K. W. Schmid, K. Mann, S. Hildenbrand, H. Hefter, S. M. Huber, T. Wieder, A. Erhardt, D. Haussinger, E. Gulbins, and F. Lang. 2007. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 13: 164-170.
20. Lee, C. J., H. R. Lin, C. L. Liao, and Y. L. Lin. 2008. Cholesterol effectively blocks entry of flavivirus. J. Virol. 82:6470-6480.
21. Lee, E., and M. Lobigs. 2002. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J. Virol. 76:4901-4911.
22. Lu, Y. E., T. Cassese, and M. Kielian. 1999. The cholesterol requirement for Sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J. Virol. 73:4272-4278.
23. Mackenzie, J. M., A. A. Khromykh, and R. G. Parton. 2007. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2:229-239.
24. Manes, S., G. del Real, and A. C. Martinez. 2003. Pathogens: raft hijackers. Nat. Rev. Immunol. 3:557-568.
25. Matsuura, Y., H. Tani, K. Suzuki, T. Kimura-Someya, R. Suzuki, H. Aizaki, K. Ishii, K. Moriishi, C. S. Robison, M. A. Whitt, and T. Miyamura. 2001. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286:263-275.
26. Mayor, S., and H. Riezman. 2004. Sorting GPI-anchored proteins. Nat. Rev. Mol. Cell Biol. 5:110-120.
27. Medigeshi, G. R., A. J. Hirsch, D. N. Streblow, J. Nikolich-Zugich, and J. A. Nelson. 2008. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J. Virol. 82:5212-5219.
28. Megha and E. London. 2004. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J. Biol. Chem. 279:9997-10004.
29. Mori, Y., T. Yamashita, Y. Tanaka, Y. Tsuda, T. Abe, K. Moriishi, and Y. Matsuura. 2007. Processing of capsid protein by cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells. J. Virol. 81:8477-8487.
30. Nawa, M., T. Takasaki, K. Yamada, I. Kurane, and T. Akatsuka. 2003. Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J. Gen. Virol. 84:1737-1741.
31. Perez, M., R. Clemente, C. S. Robison, E. Jeetendra, H. R. Jayakar, M. A. Whitt, and J. C. de la Torre. 2007. Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus. J. Virol. 81:5527-5536.
32. Porn, M. I., and J. P. Slotte. 1995. Localization of cholesterol in sphingomyelinase-treated fibroblasts. Biochem. J. 308(Part 1):269-274.
33. Ren, J., T. Ding, W. Zhang, J. Song, and W. Ma. 2007. Does Japanese encephalitis virus share the same cellular receptor with other mosquitoborne flaviviruses on the C6/36 mosquito cells? Virol. J. 4:83.
34. Reyes-Del Valle, J., S. Chavez-Salinas, F. Medina, and R. M. Del Angel. 2005. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 79:4557-4567.
35. Rothwell, C., A. Lebreton, C. Young Ng, J. Y. Lim, W. Liu, S. Vasudevan, M. Labow, F. Gu, and L. A. Gaither. 2009. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389:8-19.
36. Schenck, M., A. Carpinteiro, H. Grassme, F. Lang, and E. Gulbins. 2007. Ceramide: physiological and pathophysiological aspects. Arch. Biochem. Biophys. 462:171-175.
37. Schuchman, E. H. 2007. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J. Inherit. Metab. Dis. 30:654-663.
38. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31-39.
39. Slotte, J. P., and E. L. Bierman. 1988. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 250:653-658.
40. Stiasny, K., C. Koessl, and F. X. Heinz. 2003. Involvement of lipids in different steps of the flavivirus fusion mechanism. J. Virol. 77:7856-7862.
41. Su, C. M., C. L. Liao, Y. L. Lee, and Y. L. Lin. 2001. Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286:206-215.
42. Takada, A., C. Robison, H. Goto, A. Sanchez, K. G. Murti, M. A. Whitt, and Y. Kawaoka. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 94:14764-14769.
43. Tani, H., Y. Komoda, E. Matsuo, K. Suzuki, I. Hamamoto, T. Yamashita, K. Moriishi, K. Fujiyama, T. Kanto, N. Hayashi, A. Owsianka, A. H. Patel, M. A. Whitt, and Y. Matsuura. 2007. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J. Virol. 81:8601-8612.
44. Teichgraber, V., M. Ulrich, N. Endlich, J. Riethmuller, B. Wilker, C. C. De Oliveira-Munding, A. M. van Heeckeren, M. L. Barr, G. von Kurthy, K. W. Schmid, M. Weller, B. Tummler, F. Lang, H. Grassme, G. Doring, and E. Gulbins. 2008. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med. 14:382-391.
45. Tscherne, D. M., C. T. Jones, M. J. Evans, B. D. Lindenbach, J. A. McKeating, and C. M. Rice. 2006. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J. Virol. 80:1734-1741.
46. Utermohlen, O., J. Herz, M. Schramm, and M. Kronke. 2008. Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology 213:307-314.
47. Viola, A., and N. Gupta. 2007. Tether and trap: regulation of membrane-raft dynamics by actin-binding proteins. Nat. Rev. Immunol. 7:889-896.
48. Voisset, C., M. Lavie, F. Helle, A. Op De Beeck, A. Bilheu, J. Bertrand-Michel, F. Terce, L. Cocquerel, C. Wychowski, N. Vu-Dac, and J. Dubuisson. 2008. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell Microbiol. 10:606-617.
49. Welsch, S., S. Miller, I. Romero-Brey, A. Merz, C. K. Bleck, P. Walther, S. D. Fuller, C. Antony, J. Krijnse-Locker, and R. Bartenschlager. 2009. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe. 5:365-375.
50. Yu, C., M. Alterman, and R. T. Dobrowsky. 2005. Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1. J. Lipid Res. 46:1678-1691.